Neurology News

Opinions varied among practitioners regarding psychological support when treating with psychedelics, although an emotive approach was slightly preferred, according to results of a survey published in Journal of Clinical Psychiatry.

The effect of levetiracetam, an antiseizure therapy, on high-frequency oscillation in patients with Alzheimer’s disease as well as epilepsy may prove its viability as a biomarker of disease pathology, according to data.

The FDA has approved an oral, small molecule MEK inhibitor for adult and pediatric patients 2 years of age and older with neurofibromatosis type 1 who have symptomatic plexiform neurofibromas not amenable to complete resection.

Transplantation of neural stem cells improved neurologic and motor function for adults with chronic ischemic stroke at 12 months, according to a study presented at the International Stroke Conference.

The FDA has approved Evrysdi in tablet form for patients with spinal muscular atrophy aged 2 years and older who weigh more than 44 pounds, according to the manufacturer.

RapidAI automated imaging appeared to be more accurate than VizAI in detecting cases of large vessel occlusion, as well as in identifying those missed by its counterpart among individuals with acute stroke, results of a comparative analysis show.

The Senate voted Thursday to confirm Robert F. Kennedy Jr. to be the next HHS secretary.

The GLP-1 liraglutide showed potential benefit in reducing stroke recurrence and improving functional outcomes after minor stroke or transient ischemic attack, a speaker reported.

Individuals with a moderate to high risk for obstructive sleep apnea, as measured via the STOP-Bang questionnaire, were more likely to experience suicidal ideations, plans and attempts, according to research conducted in South Korea.